Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Van de Vijver

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Oncology|November 8, 2002
Emerging technologies for HER2 testingMarc van de Vijver
The Oncologist|November 8, 2005
Gene-expression profiling and the future of adjuvant therapyMarc van de Vijver
Cancer Treatment and Research|April 5, 2011
Estrogen receptor phenotypes defined by gene expression profilingMarleen Kok, Sabine Linn, Marc van de Vijver
Seminars in Oncology|October 19, 2004
Improving patient care through molecular diagnosticsEdith A Perez, Lajos Pusztai, Marc Van de Vijver
Cancer Research|June 20, 2019
A Tribute to John Mendelsohn: A Pioneer in Targeted Cancer TherapyRakesh Kumar, Marc Van de Vijver, Giampaolo Tortora, et al.
Breast Cancer Research : BCR|October 10, 2007
Chromogenic in situ hybridisation for the assessment of HER2 status in breast cancer: an international validation ring studyMarc van de Vijver, Michael Bilous, Wedad Hanna, et al.
Human Pathology|November 17, 2009
HER-2 amplification is highly homogenous in gastric cancerMichael Bilous, Robert Y Osamura, J Rüschoff, et al.
American Journal of Clinical Pathology|September 19, 2009
Emerging technologies for assessing HER2 amplificationFrédérique Penault-Llorca, Michael Bilous, Mitch Dowsett, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 7, 2012
HER2 testing in gastric cancer: a practical approachJosef Rüschoff, Wedad Hanna, Michael Bilous, et al.
Cancer Cell|March 11, 2008
A conditional mouse model for malignant mesotheliomaJohan Jongsma, Erwin van Montfort, Marc Vooijs, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Oncology|November 8, 2002
Emerging technologies for HER2 testingMarc van de Vijver
The Oncologist|November 8, 2005
Gene-expression profiling and the future of adjuvant therapyMarc van de Vijver
Cancer Treatment and Research|April 5, 2011
Estrogen receptor phenotypes defined by gene expression profilingMarleen Kok, Sabine Linn, Marc van de Vijver
Seminars in Oncology|October 19, 2004
Improving patient care through molecular diagnosticsEdith A Perez, Lajos Pusztai, Marc Van de Vijver
Cancer Research|June 20, 2019
A Tribute to John Mendelsohn: A Pioneer in Targeted Cancer TherapyRakesh Kumar, Marc Van de Vijver, Giampaolo Tortora, et al.
Breast Cancer Research : BCR|October 10, 2007
Chromogenic in situ hybridisation for the assessment of HER2 status in breast cancer: an international validation ring studyMarc van de Vijver, Michael Bilous, Wedad Hanna, et al.
Human Pathology|November 17, 2009
HER-2 amplification is highly homogenous in gastric cancerMichael Bilous, Robert Y Osamura, J Rüschoff, et al.
American Journal of Clinical Pathology|September 19, 2009
Emerging technologies for assessing HER2 amplificationFrédérique Penault-Llorca, Michael Bilous, Mitch Dowsett, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 7, 2012
HER2 testing in gastric cancer: a practical approachJosef Rüschoff, Wedad Hanna, Michael Bilous, et al.
Cancer Cell|March 11, 2008
A conditional mouse model for malignant mesotheliomaJohan Jongsma, Erwin van Montfort, Marc Vooijs, et al.
Pageof 3